Epigral, a leading integrated chemical manufacturer in India, formerly known as Meghmani Finechem, has announced a significant expansion into the production of Chlorinated polyvinyl chloride (CPVC) Compounds. Their new manufacturing plant in Dahej, Gujarat, is set to have a capacity of 35,000 Tons Per Annum (TPA) and is anticipated to be operational by the fourth quarter of the financial year 2024.
This expansion follows Epigral’s previous milestone in July 2022 when they successfully commissioned a CPVC Resin facility with a capacity of 30,000 TPA. Building on this achievement, the company is now aiming to further increase its CPVC Resin capacity to 75,000 TPA by the same target date in Q4FY24. Part of this expanded capacity will be dedicated to CPVC Compound manufacturing, requiring an additional investment of Rs. 25 Crores. This strategic move positions Epigral to serve both CPVC Resin and CPVC Compound customers across the country.
CPVC Resin is known for its resistance to high temperatures and chemicals, making it a valuable material for the production of pipes used in various industrial and domestic applications. It’s worth noting that India currently relies on imports to meet its demand for CPVC Resin and CPVC Compounds. With Epigral’s entry into CPVC Compound manufacturing, the company aims to bolster domestic supply, contributing significantly to closing the demand-supply gap in this vital industry.
Speaking on the development, Maulik Patel, Chairman & Managing Director, of Epigral Limited said: “We have been expansively contributing to this market for over a year now, which has enabled us to gather invaluable market and sector insights. Intensified growth of the construction industry in India, along with growing applications of CPVC, presents immense growth opportunities”
“This expansion is in synergy with our capex of CPVC Resin. As an aspirational and dynamic company, we are expecting more expansions in the future to keep our growth momentum consistent,” Patel added.